Product Code: CMI3965
A microkeratome is a high-precision surgical instrument used for Anterior Lamellar Keratoplasty (ALK) or Laser Eye Surgery (LASIK). A microkeratome comprises of an oscillating blade that is intended to create the corneal flap for surgeries allied to refractive errors. This surgical instrument is used in DSAEK (Descemet's Stripping Automated Endothelial Keratoplasty) to cut a reedy layer from the cornea's back which is then relocated into the inheritor's cornea. The microkeratome and vacuum units are assembled, tested, and inspected before the surgery, , to confirm appropriate functioning.
Market Dynamics
Factors such as the rising prevalence of eye disorders and the growing geriatric population are expected to propel the microkeratome market growth in the future. According to the World Health Organization (WHO), uncorrected cataracts and refractive errors are the leading cause of vision impairment. In 2021, there were around 2.2 billion people suffering from eye disorders or vision impairment.
Governments of various countries in Asia Pacific are investing in improving healthcare infrastructure which is estimated to fuel market growth during the forecast period.
Moreover, governments of various countries are promoting awareness regarding eye disorders and vision impairment. However, the dearth of skilled professionals is predicted to restrict the market growth during the forecast period.
Key features of the study:
- This report provides in-depth analysis of the global microkeratome market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year
- It elucidates potential revenue opportunity across different segments and explains an attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
- It profiles key players in the global microkeratome market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, key developments, and strategies
- Key players covered as a part of this study are Essilor International, Bausch & Lomb Incorporated, Johnson & Johnson Vision Care, CooperVision, Carl Zeiss AG, Hoya Corporation, Alcon, Inc., STAAR Surgical Company, Marvel Medtech, Abbott Medical Optics Inc., Novartis AG, HAAG-Streit Holding AG, Nidek Co., Ltd., Valeant Pharmaceuticals International, Inc., Sonomed Escalon, Topcon Corporation, Gulden Ophthalmics, FCI Ophthalmics, Ziemer Ophthalmic Systems AG, and Glaukos Corporation
- Insights from this report would allow marketers and management authorities of companies to make an informed decision with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
- The global microkeratome market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for microkeratome market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
- Global Microkeratome Market, By Product:
- Global Microkeratome Market, By End User:
- Hospitals
- Ophthalmic Centers
- Others
- Global Microkeratome Market, By Treatment:
- Retinal Detachment
- Epiretinal Membrane
- Diabetic Retinopathy
- Others
- Global Microkeratome Market, By Region:
- North America
- U.S.
- Canada
- Reusable
- Disposable
- Orthopedic
- Others
- Hospitals
- Ophthalmic Centers
- Others
- Retinal Detachment
- Epiretinal Membrane
- Diabetic Retinopathy
- Others
- Europe
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Reusable
- Disposable
- Orthopedic
- Others
- Hospitals
- Ophthalmic Centers
- Others
- Retinal Detachment
- Epiretinal Membrane
- Diabetic Retinopathy
- Others
- Asia Pacific
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- Reusable
- Disposable
- Orthopedic
- Others
- Hospitals
- Ophthalmic Centers
- Others
- Retinal Detachment
- Epiretinal Membrane
- Diabetic Retinopathy
- Others
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Reusable
- Disposable
- Orthopedic
- Others
- Hospitals
- Ophthalmic Centers
- Others
- Retinal Detachment
- Epiretinal Membrane
- Diabetic Retinopathy
- Others
- Middle East
- GCC
- Israel
- Rest of Middle East
- Reusable
- Disposable
- Orthopedic
- Others
- Hospitals
- Ophthalmic Centers
- Others
- Retinal Detachment
- Epiretinal Membrane
- Diabetic Retinopathy
- Others
- Africa
- South Africa
- Central Africa
- North Africa
- Reusable
- Disposable
- Orthopedic
- Others
- Hospitals
- Ophthalmic Centers
- Others
- Retinal Detachment
- Epiretinal Membrane
- Diabetic Retinopathy
- Others
- Company Profiles
- Essilor International
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Johnson & Johnson Vision Care
- Bausch & Lomb Incorporated
- CooperVision
- Hoya Corporation
- Carl Zeiss AG
- Alcon, Inc.
- Marvel Medtech
- STAAR Surgical Company
- Abbott Medical Optics Inc.
- Novartis AG
- HAAG-Streit Holding AG
- Nidek Co., Ltd.
- Topcon Corporation
- Valeant Pharmaceuticals International, Inc.
- Ziemer Ophthalmic Systems AG
- Sonomed Escalon
- Gulden Ophthalmics
- FCI Ophthalmics
- Glaukos Corporation
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product
- Market Snippet, By End User
- Market Snippet, By Treatment
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Technological Advancements for Refractive Surgery
- Key Developments
- Acquisition, Collaborations & Partnerships
- Epidemiology
4. Global Microkeratome Market, Impact of Coronavirus (Covid-19) Pandemic
- Pre-COVID situation
- Post-COVID demand
- Need for Microkeratome
- Recommendations and guidelines by regulatory bodies
5. Global Microkeratome Market, By Product, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Reusable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Disposable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
6. Global Microkeratome Market, By End User, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Ophthalmic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
7. Global Microkeratome Market, By Treatment, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Retinal Detachment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Epiretinal Membrane
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Diabetic Retinopathy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
8. Global Microkeratome Market, By Region, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, By Region, 2017 - 2028
- Regional Trends
- North America
- Market Size and Forecast, By Product, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Treatment, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Product, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Treatment, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Product, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Treatment, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, By Product, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Treatment, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Africa
- Market Size and Forecast, By Product, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Treatment, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country/Region, 2017 - 2028, (US$ Million)
- North Africa
- Central Africa
- South Africa
- Middle East
- Market Size and Forecast, By Product, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Treatment, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- GCC
- Israel
- Rest of Middle East
9. Competitive Landscape
- Company Profiles
- Essilor International
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Bausch & Lomb Incorporated
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Johnson & Johnson Vision Care
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- CooperVision
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Carl Zeiss AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Hoya Corporation
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Alcon, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- STAAR Surgical Company
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Marvel Medtech
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Abbott Medical Optics Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Novartis AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- HAAG-Streit Holding AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Nidek Co., Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Valeant Pharmaceuticals International, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Sonomed Escalon
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Topcon Corporation
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Gulden Ophthalmics
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- FCI Ophthalmics
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Ziemer Ophthalmic Systems AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Glaukos Corporation
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
10. Section
- References
- Research Methodology
- About Us and Sales Contact